Investing Profile

Eric Anschutz

AngelInvestorScoutAdvisor

Experienced angel with biotech focus. Selective deal flow supported by quantitative evaluation system. Proven, exit-driven results over 15+ years. Bike lover.

angel.co/s/anschutz/2oq0tSan Francisco, California
Photo of Eric Anschutz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$10K - $250K
$25K
32
CompanyStageDateRound SizeTotal Raised
Avery
SeedNov 2022$1
$1
Attivare Therapeutics
SeedJun 2021$1
$5M
Co-investors: Maximilian Winter (Harmonix Fund)
Primordial Genetics
Seed RoundFeb 2021$1
$1
HDT Bio
Seed RoundFeb 2021$6M
Seed RoundOct 2020$6M
$12M
SMBX
Seed RoundAug 2020$2.5M
$5M
Co-investors: Wes Selke (Better Ventures), Jordan Fliegel (Techstars)
OccamzRazor
Seed RoundMay 2019$4.5M
Seed RoundFeb 2017
$4.5M
Co-investors: Phil Libin (General Catalyst), Ajay Singh (01 Ventures), Nate Dalton (Daybreak Partners), DA Wallach (Time BioVentures), Justin Rosenstein
MycoWorks
Venture RoundOct 2018
SeedMar 2018$1
$45M
Co-investors: Arvind Gupta (SOSV), Po Bronson (SOSV), Tony Fadell (Future Shape), Seth Berman (Susa Ventures), John Legend
Notable Labs
Series BSep 2017$15M
$76M
Co-investors: John Kim (AMASIA), Ramanan Raghavendran (AMASIA), Milad Alucozai (BoxOne Ventures), John Noonan (Lifeforce Capital), Chris Sklarin (Alumni Ventures Group), Anton Simunovic (Alumni Ventures Group), Charlie Pinto (Bling Capital), Stefano Bernardi (Atomico), Jim Kim (Builders VC), Ross Blankenship (Recharged Partners), Kevin Mahaffey (SNR), Ian McNish
Biotech, Synthetic Biology, Bicycles, Medical Bioinformatics, Genomics, Genetic Testing, Biotechnology, DNA/RNA, Microbiome, Quantified Self, Medical Devices, Internet of Things, Pharmaceuticals, Bio-Pharma